Phase 3 Clinical Trial Confirms SaNOtize’s Breakthrough Treatment is 99% Effective Against COVID-19; Receives Regulatory Approval in India
Glenmark launches Nitric Oxide Nasal Spray (FabiSpray®) in India for the Treatment of Adult Patients with COVID-19 in partnership with SaNOtize
Glenmark and SaNOtize announce positive Results from Phase 3 Clinical Trial of NONS (FabiSpray®) in Non-Hospitalized Adult Indian Patients with COVID-19
>>724
February 9, 2022
Phase 3 Clinical Trial Confirms SaNOtize’s Breakthrough Treatment is 99% Effective Against COVID-19; Receives Regulatory Approval in India
Glenmark launches Nitric Oxide Nasal Spray (FabiSpray®) in India for the Treatment of Adult Patients with COVID-19 in partnership with SaNOtize
Glenmark and SaNOtize announce positive Results from Phase 3 Clinical Trial of NONS (FabiSpray®) in Non-Hospitalized Adult Indian Patients with COVID-19
インドやカナダやイスラエルの人が羨ましい。